Back to the Top
I will appreciate if any one can share his experience on the biowaiver
of borderline class I drug for US and EU market.
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Biowaiver of Borderline class I drug" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)